Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Cisapride Compounded is dosed at 0.1–0.5 mg/kg PO q8h in dogs, per Whitehead K, Cortes Y, Eirmann L. Gastrointestinal dysmotility disorders in critically ill dogs and cats. J Vet Emerg Crit Car. 2016;26(2):234-253. doi:10.1111/vec.12449 — Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.297 (2026-08-01). — Plumb's 10th ed (held) printed p.270, Cisapride monograph spanning p.269-270; page located 2026-08-05 from the book's own running heads, and carries this exact dose under the matching species heading. — SOURCE EDITION: Plumb's Veterinary Drug Handbook — ISBN 9781394172207, https://openlibrary.org/isbn/9781394172207. Cisapride Compounded is used in dogs for Gastric motility disorders. Routes documented in dogs: PO. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 1 cited dose rule for Cisapride Compounded in dogs, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Compounded Cisapride
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| PO | 0.1–0.5 mg/kg | q8h | Long-term for chronic motility disorders | Gastric motility disorders | Moderate | Whitehead K, Cortes Y, Eirmann L. Gastrointestinal dysmotility disorders in critically ill dogs and cats. J Vet Emerg Crit Car. 2016;26(2):234-253. doi:10.1111/vec.12449 — Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.297 (2026-08-01). — Plumb's 10th ed (held) printed p.270, Cisapride monograph spanning p.269-270; page located 2026-08-05 from the book's own running heads, and carries this exact dose under the matching species heading. — SOURCE EDITION: Plumb's Veterinary Drug Handbook — ISBN 9781394172207, https://openlibrary.org/isbn/9781394172207 |
Every held source for this drug and species, as printed. Where they differ, both are shown — the choice is yours, not ours.
| Dose (mg/kg) | Route | Source | As printed |
|---|---|---|---|
| 0.1–0.5 | PO | BSAVA Small Animal Formulary, 10th ed — Part A (Canine and Feline)p.104 | 0.1-0.5 mg/kg p.o. q8-12h; some recommend giving 30 minutes before feeding. Some sources state that gra |
| 1 | PO | BSAVA Small Animal Formulary, 10th ed — Part A (Canine and Feline)p.104 | me sources state that gradually increasing doses up to 1 mg/kg p.o. q8h may be required (if tolerated) |
Figures are transcribed from the cited page or table of each held edition and are shown for reference only. They are not dose recommendations, they do not feed the calculator, and none has been reviewed by a veterinarian.
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
5-HT4 receptor agonist that enhances acetylcholine release in myenteric plexus, increasing GI motility throughout the GI tract. Also weak 5-HT3 antagonist.
Removed from human market (cardiac arrhythmias) but available compounded for veterinary use. QT prolongation risk. Do not combine with azole antifungals or erythromycin.
Species-specific contraindications and adverse-reaction reports for dogs may differ from canine / feline reference data — consult the primary citations listed with each rule.
Cisapride Compounded dose range in dogs, with cited source references: PO 0.1–0.5 mg/kg q8h. Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Cisapride Compounded in dogs: PO.
Cited course lengths for Cisapride Compounded in dogs include: Long-term for chronic motility disorders. Duration depends on the indication — match it to the specific dose rule in the table above.
Cisapride Compounded is indicated in dogs for: Gastric motility disorders.
These are general warnings for Cisapride Compounded across species; consult the dog dosing table above for species-specific guidance. Removed from human market (cardiac arrhythmias) but available compounded for veterinary use. QT prolongation risk. Do not combine with azole antifungals or erythromycin.
Why a species-specific page? Cisapride Compounded pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dogs — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.